European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Testicular Cancer

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
2023
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • No elements found. Consider changing the search query.
  • List is empty.

Summary of changes

For the 2023 Testicular Cancer Guidelines, a new literature search was not performed.   However, the panel concentrated on a forensic review of all the recommendations and supporting text.   This resulted in a few key changes including:

  • Replacing some of the older citations with newer references.
  • The recent re-validation of the 1997 International Germ Cell Cancer Collaborative Group (IGCCCG) prognostic risk-factor based system for metastatic testicular Germ cell tumours in patients treated with cisplatin-etoposide as first-line chemotherapy has been included in the text replacing the old version with the corresponding references;
  • New supporting text regarding VTE prophylaxis in males with metastatic germ cell tumours (GCTs) receiving chemotherapy has been added;
  • Update of the histological classifications in sections 3.2 as well as inclusion of the World Health Organization (WHO) 2022 pathological classification;
  • Three appendices on computerised tomography; prevention of thromboembolism and quality of life and long-term toxicities after cure of testicular cancer; have been created and will be available online at https://uroweb.org/guidelines/testicular-cancer/publications-appendices.

For the 2024 print a broad and comprehensive literature search, covering all sections of the Testicular Cancer guideline, will be performed and all new and relevant evidence will be identified, collated and appraised through a structured assessment.  

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer